← Product Code [DPS](/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS) · K100813 # QRS CARD S-T SEGMENT ANALYSIS PATIENT MONITORING SYSTEM MODEL: QRS CARD USB (K100813) _Pulse Biomedical, Inc. · DPS · Jul 23, 2010 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS/K100813 ## Device Facts - **Applicant:** Pulse Biomedical, Inc. - **Product Code:** [DPS](/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS.md) - **Decision Date:** Jul 23, 2010 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 870.2340 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular ## Indications for Use This device is intended for use as a patient monitor for any patient undergoing ECG S-T Segment Analysis and/or ECG stress analysis during rest or exercise. Exercise can be performed treadmill or bicycle ergometer use. The intended use locations are either in a physician's office, hospital or rehabilitation facilities, or similar use areas. It is intended to be used by or on the order of a physician or similarly qualified health care professional. This device is intended for use in a hospital environment, physician's office, or similar settings. This device is not intended for home use. ## Device Story QRS Card™ S-T Segment Analysis Patient Monitoring System converts standard PCs into ECG monitors with ST segment measurement capabilities. System components include QRS CARD™ Office ECG device, patient cable/lead wires, and software. Input consists of ECG signals acquired from patients via lead wires; data transmitted to PC via Bluetooth wireless technology. Software processes signals to perform ST segment analysis and stress testing. Output displayed on PC screen for physician review; results can be printed or saved for future analysis. Used in hospitals, physician offices, or rehabilitation facilities by physicians or qualified healthcare professionals. Facilitates clinical decision-making through real-time monitoring and diagnostic data generation during rest or exercise. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Physiological monitor (Electrocardiograph). Components: ECG hardware, patient cables, PC-based software. Connectivity: Bluetooth wireless transmission. Energy source: PC-powered/battery. Environment: Clinical/hospital. Software-based analysis of ECG signals for ST segment measurement. ## Regulatory Identification An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart. ## Predicate Devices - QRS CARD™ S-T Segment Analysis Patient Monitoring System ([K972255](/device/K972255.md)) - PC ECG 1200W System ([K080141](/device/K080141.md)) - Plex 04 Wireless Electrocardiograph with Software Accessories ([K061977](/device/K061977.md)) - BR3/6, BR12 ([K082077](/device/K082077.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ # Attachment A. 510(k) Summary Image /page/0/Picture/20 description: The image shows a logo with two distinct elements. On the left, there is a hexagonal shape filled with a textured pattern, and within it, a stylized electrocardiogram (ECG) waveform is visible. To the right of the hexagonal shape, the letters 'PBI' are printed in a bold, sans-serif font. The overall design appears to be for a company or organization with the initials PBI, possibly related to healthcare or cardiology. **JUL 28 2010** Ise Biomedical, Inc **Pulse Biomedical GmbH** Filhete Bihler Str 4, 72474 Winterlingen, GERALANY Tel: +49-7434-316038 Fax:+49-7434-316039 Special 510(k) - QRS Card™ S-T Segment Analysis Patient Monitoring System Modification Section 6 510(k) Summary - 807.92 ## Applicant Name and Address Pulse Biomedical Inc. 1305 Catfish Lane Norristown, PA 19403 #### Manufacturer Name and Address Pulse Biomedical Inc. 1305 Catfish Lane Norristown PA 19403 #### Contact Person Saleem Hasan - President Tel. No. - 610-660-5510 Fax No. - 610-666-5630 Establishment Registration Number 2529508 Device Name: | Device
Trade
Name | Common
Classification
/ Name | Regulation
Number | Classification
Code | Device
Class | Classification
Name | |-------------------------|------------------------------------|----------------------|------------------------|-----------------|------------------------| | QRS
Card BT | Physiological
Monitor | N/A | DPS | II | Electrocardiograph | {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows a logo with two distinct elements. On the left, there is a stylized hexagon shape with a jagged line running through the center, resembling a heartbeat or electrical signal. To the right of the hexagon, the letters 'PBI' are printed in a bold, sans-serif font. The overall design is simple and professional. 1305 Catfish Lane, Norristown, PA 19403, USA Tel: 610-666-5510 Fax: 610-666-5630 Wuneim Binler Str 4, 72474 Winterlingen, GERMANY Tel: +49-7434-316038 Fax: +49-7434-316039 # Special 510(k) - QRS Card™ S-T Segment Analysis Patient Monitoring System Modification ## Legally Marketed Devices to Which Substantial Equivalence is Claimed | 510(k) Number | Trade Name | Company | |---------------|---------------------------------------------------------------------|------------------------| | K972255 | QRS CARD™ S-T Segment
Analysis Patient Monitoring
System | Pulse Bio Medical Inc. | | K080141 | PC ECG 1200W System | Norav Medical LTD | | K061977 | Plex 04 Wireless
Electrocardiograph with
Software Accessories | PinMed, Inc. | | K082077 | BR3/6, BR12 | Coscience GmbH & Co KG | ### Device Description: The QRS CARD™ S-T Segment Analysis Patient Monitoring System converts a commercially available personal computer (PC) into an ECG monitor with ST segment measurement capability. Physicians can initiate ST evaluations on patients and the data are transmitted, using Bluetooth wireless technology, to a computer screen. Test results can also be printed at any time during the testing, or saved in computer memory for future review or additional report generation. The QRS CARD™ S-T Segment Analysis Patient Monitoring System consists of the following components: - The QRS CARD™ Office ECG Device ● - ECG Patient Cable and Lead Wires ● - Product Software on CD . - User Manual . #### Intended Use: This device is intended for use as a patient monitor for any patient undergoing ECG S-T Segment Analysis and/or ECG stress analysis during rest or exercise. Exercise can be performed treadmill or bicycle ergometer use. The intended use locations are either in a physician's office, hospital or rehabilitation facilities, or similar use areas. It is intended to be used by or on the order of a physician or similarly qualified health care professional. This device is intended for use in a hospital environment, physician's office, or similar settings. This device is not intended for home use. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows a logo with two distinct elements. On the left, there is a stylized, geometric shape resembling a hexagon with a jagged line running through its center, possibly representing a heartbeat or signal. To the right of this shape, the letters 'PBI' are printed in a bold, sans-serif font. The overall design is simple and professional, suggesting a company or organization with a focus on precision or technology. #### Pulse Biomedica 1/3 -666-5630 # Special 510(k) - QRS Card™ S-T Segment Analysis Patient Monitoring System Modification ## Conclusion: The technological characteristics of the QRS CARD™ S-T Segment Analysis Patient Monitoring System are safe and effective and substantially equivalent to the legally marketed predicate devices. {3}------------------------------------------------ ### DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Pulse Biomedical, Inc. c/o Mr. Saleem Hasan President 1305 Catfish Lane Norristown, PA 19403 # JUL 2 3 2010 K100813 Re: Trade/Device Name: QRS Card™ ST-Segment Analysis Patient Monitoring System Regulatory Number: 21 CFR 870.2340 Regulation Name: Electrocardiograph Regulatory Class: Class II (Two) Product Code: DPS Dated: June 22, 2010 Received: June 23, 2010 Dear Mr. Hasan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for assession to May 28, 1976, the enactment date of the Medical Device Amendments, or to conninered processified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). and coosmeter fore, market the device, subject to the general controls provisions of the Act. The I ca mayy nevels provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {4}------------------------------------------------ #### Page 2 - Mr. Saleem Hasan Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely vours. buna R. Vohrer Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ Image /page/5/Picture/0 description: The image shows a logo with the letters "PBI" to the right of a hexagonal shape. Inside the hexagon is a line graph that resembles a heartbeat. The hexagon is textured with a rough, possibly stone-like pattern. The letters "PBI" are in a simple, bold font. Pulse Biomedical, Inc. 1305 Catfish Lane, Norristown, PA 19403, USA el: 610-666-5510 Pulse Biomedical GmbH Wilhelm Bihler Str 4; 72474 Winterlingen, GERMANY 49-7434-316038 Special 510(k) - QRS Card™ S-T Segment Analysis Patient Monitoring System Modification Section 4 Indications for Use Statement 510(k) Number: _______________________________________________________________________________________________________________________________________________________________ (if known) Device Name: QRS Card™ S-T Segment Analysis Patient Monitoring System Indications for Use: This device is intended for use as a patient monitor for any patient undergoing ECG S-T Segment Analysis and/or ECG stress analysis during rest or exercise. Exercise can be performed treadmill or bicycle ergometer use. The intended use locations are either in a physician's office, hospital or rehabilitation facilities, or similar use areas. It is intended to be used by or on the order of a physician or similarly qualified health care professional. This device is intended for use in a hospital environment, physician's office, or similar settings. This device is not intended for home use. PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of the CDRH, Office of Device Evaluation (ODE) Prescription Use X OR Over the Counter Use Dina P. Weiner (Division Sign-Off) Division of Cardiovascular Devices 510(k) Number_ K100813 --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS/K100813](https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS/K100813) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com